カワムラ ヒデマサ
KAWAMURA Hidemasa
河村 英将 所属 埼玉医科大学 医学部 総合医療センター 放射線科(画像診断・核医学科、放射線腫瘍科) 職種 教授 |
|
論文種別 | 学術雑誌(原著) |
言語種別 | 英語 |
査読の有無 | 査読あり |
表題 | Inoperable Pancoast tumors treated with hyperthermia-inclusive multimodality therapies |
掲載誌名 | 正式名:LUNG CANCER ISSNコード:0169-5002 |
出版社 | ELSEVIER IRELAND LTD |
巻・号・頁 | 63(2),247-250頁 |
著者・共著者 | Takeshi Ebara,Hideyuki Sakurai,Masaru Wakatsuki,Tetuso Nonaka,Hitoshi Ishikawa,Hidemasa Kawamura,Daisaku Yoshida,Mariko Shioya,Yuko Nakayama,Takashi Nakano |
発行年月 | 2009/02 |
概要 | Purpose: This study aimed to assess the feasibility, efficacy and complication of hyperthermia-inclusive multimodality therapies for patient with inoperable Pancoast tumor. Material and methods: Five patients with inoperable Pancoast tumor were treated with hyperthermia-inclusive multimodality therapies. They received thermoradiotherapy with/without chemotherapy. Radiation therapy was delivered using 10 MV X-rays with total dose of 68-70 Gy. In the latter half of the radiation therapy hyperthermia was performed for 2-4 sessions once a week with 8 MHz radiofrequency device. Results: For primary response, 4 tumors showed partial response to the treatment with the exception of 1 tumor who showed stable disease. Only one patient was with a short follow-up period (9 months), all other patients survived 3 years or more without recurrence. Of them, 2 patients were recognized with local recurrence at 38.7 and 42.7 months after treatment and died at 66.9 and 78.5 months after treatment. The other 2 patients are disease-free survivor for 4 and 5 years after treatment. No severe non-hematological toxicity was observed in each patient. Conclusion: These data suggested that hyperthermia-inclusive multimodality therapies might be a promising approach for inoperable Pancoast tumor. (C) 2008 Elsevier Ireland Ltd. All rights reserved. |
DOI | 10.1016/j.lungcan.2008.05.023 |
PMID | 18620779 |